|
|
Article: Chimerix, Inc. Appoints Kenneth I. Moch Chief Operating Officer.
- Article from:
- PR Newswire
- Article date:
- July 16, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
RESEARCH TRIANGLE PARK, N.C., July 16 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally available antiviral therapeutics, announced today that Kenneth I. Moch has joined the company as Chief Operating Officer.
Mr. Moch brings more than 25 years of experience in managing and financing biomedical technologies, and has played a key role in building several life science companies. In this newly-created position, Mr. Moch will be responsible for overseeing corporate and financial strategy, business development and operations, reporting to George Painter, Ph.D., Chimerix's President and Chief Executive Officer.
"Ken is a seasoned ...
Related newspaper, magazine, and journal articles:
|
|
Article: Chimerix Awarded NIH Grant to Fund Drug Development for ...
PR Newswire;
March 11, 2004 ;
700+ words
... ... SAN DIEGO, March 11 /PRNewswire/ -- Chimerix Inc., a biotechnology company developing ... potential to succeed as commercial products. Chimerix will use the two year, $600,000 grant ... Painter, Ph.D., President and CEO of Chimerix. "New classes of anti-retroviral ...
|
|